Sat, Mar 25, 2017
In 2015, Europe banned around 700 medicines that had been approved based on clinical trial data provided by GVK Biosciences, then India’s largest CRO.
More >
Fri, Aug 26, 2016
Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Top 5 stories of this afternoon: 1.Nifty slips below 8,600 as September series start
Biocon informed that EMA has accepted for review of Mylan's market authorization application (MAA) for a proposed biosimilar Trastuzumab, which is used to treat certain breast and gastric cancer.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
